Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$37.01 USD
+0.77 (2.12%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $37.03 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/29/2024
Time: -- |
6/2024 | $-0.31 | -6.14% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.54 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for APLS's next earnings release expected on July 29, 2024. For the next earning release, we expect the company to report earnings of -$0.31 per share, reflecting a year-over-year increase of 69.61%.
Earnings History
Price & Consensus
Zacks News for APLS
Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services